Group 1 - The company, Chongqing Taiji Industrial (Group) Co., Ltd., plans to acquire 100% equity of Chongqing Tongjun Pavilion Traditional Chinese Medicine Wholesale Co., Ltd. by purchasing 90% from Chongqing Chinese Medicinal Materials Co., Ltd. for 21.08 million yuan and 10% from Taiji Group Chongqing Fuling Pharmaceutical Co., Ltd. for 2.35 million yuan [2][3][14] - The equity transfer has been approved by the company's board of directors and does not require shareholder approval as it falls within the board's authority [4][15] - The transaction does not constitute a related party transaction or a major asset restructuring as per the relevant regulations [4][15] Group 2 - Chongqing Tongjun Pavilion Traditional Chinese Medicine Wholesale Co., Ltd. has total assets of 77 million yuan, net assets of 23.42 million yuan, operating income of 136.03 million yuan, and net profit of 2.91 million yuan as of December 31, 2024 [6] - Chongqing Chinese Medicinal Materials Co., Ltd. has total assets of 358.31 million yuan, net assets of 55.29 million yuan, and operating income of 409.18 million yuan, but reported a net loss of 18.19 million yuan as of December 31, 2024 [7] - Taiji Group Chongqing Fuling Pharmaceutical Co., Ltd. has total assets of 231.27 million yuan, net assets of 58.46 million yuan, and operating income of 315.24 million yuan, with a net profit of 2.05 million yuan as of December 31, 2024 [9] Group 3 - The acquisition aims to optimize the company's equity structure and consolidate internal resources, ensuring that the company holds 100% of Chongqing Tongjun Pavilion after the transfer [3][15] - The financial impact of the equity transfer is neutral, as it does not change the consolidation scope or adversely affect the company's financial and operational status [15] - The company will enhance management and control over the subsidiary's operations post-acquisition [16]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：600667 证券简称：太极实业 公告编号：临2026-007 无锡市太极实业股份有限公司 关于子公司十一科技项目预中标公示的 提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要事项提示： ●截至目前，项目尚处于中标人公示阶段，联合体最终能否获得中标通知书仍存在一定的不确定性。如 能确定中标并签订正式合同，因项目存在跨年实施，且受合同签订时间、开工日期及实施进度影响，对 公司2026年度业绩的影响存在不确定性。 近日，无锡市太极实业股份有限公司（以下简称"公司"）子公司信息产业电子第十一设计研究院科技工 程股份有限公司（以下简称"十一科技"）与上海建工四建集团有限公司（以下简称"上海四建"）组成联 合体，参与了华虹宏力半导体（无锡）有限公司的华虹FAB9B项目工程总承包（以下简称"项目"）的投 标。根据无锡市公共资源交易中心发布的《无锡市工程建设项目中标人公示（编号：WXXQ202601001- X01）》（https://ggzyjy.wuxi.gov ...

Group 1 - Company X is currently undergoing auditing and evaluation work [1] - Company Y has not yet received any orders in the "space photovoltaic" sector [1] - Company Z plans to invest 1 billion yuan in the construction of a synthetic biology manufacturing project in Xinjiang [1] Group 2 - Company A has won a 994 million yuan EPC project [1] - Company B's subsidiary has secured a project worth 101 million yuan [1] - Company C's subsidiary is expected to be awarded a project for the total engineering contract of Huahong FAB9B [1] Group 3 - Company D reported a net profit of 177 million yuan for 2025, representing a year-on-year increase of 42.81% [1] - Company E reported a net profit of 34.93 million yuan for 2025, with a year-on-year growth of 30.13% [1] Group 4 - Company F plans to acquire a portion of equity in Company G, which will increase its holding and achieve control [1] - Company H and its subsidiary plan to transfer 80% of the equity in Wuhan Shengchong [1] Group 5 - Company I has completed the repurchase of 875,000 shares [2] - Company J plans to raise no more than 5 billion yuan through a private placement for a 20GWh power battery project [2] - Company K's actual controller is under investigation by the China Securities Regulatory Commission for alleged market manipulation [2]

证券日报网讯 2月5日，太极实业发布公告称，公司子公司十一科技与上海四建组成联合体，被公示为 华虹宏力半导体（无锡）有限公司华虹FAB9B项目工程总承包拟中标人，投标报价3777540536.50元， 工期350日历天，十一科技预计承担98.46%工作量对应金额约为37.19亿元。 （文章来源：证券日报） ...

以下是第一财经对一些重要公告的汇总，供投资者参考。 【品大事】 正和生态：与北京市密云区政府签署战略合作协议 正和生态公告，公司与北京市密云区政府签署战略合作协议，公司将依托生态水利基础设施等优势，为密云区政府提供水安全、水资源、水生态、水科技等 全链条服务。 两连板协鑫集成：公司暂未获得"太空光伏"领域的相关订单 协鑫集成发布股票交易异常波动的公告，近期，资本市场对"太空光伏"等前沿概念板块关注度较高，相关板块二级市场表现活跃。公司主要产品覆盖高效光 伏电池、大尺寸光伏组件、储能系统等，并为客户提供智慧光储一体化集成方案，包含绿色能源工程相关的产品设计、定制、生产、安装、销售等一揽子服 务内容，公司产品与服务主要应用于地面光伏场景。目前"太空光伏"尚处技术探索阶段，其技术路径、产业模式及商业化前景均存在不确定性。截至目前， 公司暂未获得"太空光伏"领域的相关订单。该领域未对公司经营业绩产生实质影响，未来是否能够带来业务机会亦存在不确定性。 长芯博创：股东ZHU WEI终止转让公司5.04%股份 长芯博创公告称，因客观条件变化，公司持股5%以上股东ZHU WEI（朱伟）终止向宁波宁聚转让其持有的公司无限售流通 ...

Group 1 - Company Jianhui Information plans to acquire 38% equity in Boke Guoxin for RMB 73.71 million, increasing its stake from 32% to 70%, making Boke Guoxin a subsidiary [1] - Company Guangshengtang's innovative drug GST-HG141 for hepatitis B has completed the enrollment of 578 participants in its Phase III clinical trial [2] - Company Hongjing Optoelectronics is establishing a partnership with a target scale of RMB 290 million, contributing RMB 3 million as a limited partner [3] Group 2 - Company Hongchang Technology intends to acquire 21% equity in Liangzhi Joint, which will make it the controlling shareholder with a 51% stake [4] - Company Xiexin Integrated has not yet received any orders in the "space photovoltaic" sector, which remains in the exploratory phase [5] - Company Xianheng International plans to reduce its shareholding by up to 3%, amounting to a maximum of 12.28 million shares [6] Group 3 - Company Furuijia plans to reduce its repurchased shares by up to 2%, totaling 18.93 million shares [7] - Company Tianqimo is planning to issue shares and pay cash to acquire assets, leading to a temporary suspension of its stock [8] - Company Shuangqiang Technology's director plans to reduce his holdings by up to 0.32% [9] Group 4 - Company Bairun plans to adjust the conversion price of its bonds due to stock prices falling below 85% of the conversion price [11] - Company Dongnan Network has won an EPC project worth RMB 994 million [12] - Company Anhui Energy has appointed Xu Wengong as the new general manager following the resignation of Fang Shiqing [13] Group 5 - Company Lijun plans to invest up to USD 3 million to establish subsidiaries in Hong Kong and Peru [14] - Company Zhenghe Ecology has signed a strategic cooperation agreement with the government of Beijing's Miyun District [15] - Company First Venture has elected Guo Chuan as the chairman of its board [16] Group 6 - Company Changxin Bochuang's shareholder has terminated an agreement to transfer 14.5 million shares [17] - Company Hengrui Medicine's HR091506 tablet application has been accepted by the National Medical Products Administration [18] - Company Hengrui Medicine's SHR-1894 injection has received approval for clinical trials [20] Group 7 - Company Longshen Rongfa has obtained a medical device production license [21] - Company Western Securities reported that its new borrowings exceeded 20% of its net assets [22] - Company Rongfa Nuclear Power's subsidiary has won a project worth RMB 101 million [23] Group 8 - Company Taiji Industry's subsidiary has a pre-bid for the Huahong FAB9B project with a bid amount of RMB 3.778 billion [24] - Company Suzhou High-tech plans to increase its investment in a subsidiary by RMB 780 million through a debt-to-equity swap [26] - Company Electric Power Investment's vice president has resigned due to work changes [27] Group 9 - Company Hengwei Technology reported a 30.13% increase in net profit for 2025 [28] - Company Fangsheng Pharmaceutical's subsidiary has received a drug production license [29] - Company Pilin Bio's subsidiary has received a notice for clinical trial acceptance for a hemostatic drug [31] Group 10 - Company Zhongxin Fluorine Material has received approval for a stock issuance to specific investors [32] - Company Shanhe Intelligent expects a total transaction amount with related parties to be RMB 1.197 billion in 2026 [33] - Company Warner Pharmaceutical's partner has completed Phase I clinical trials for a new drug [34]

（原标题：太极实业(600667.SH)：子公司十一科技预中标华虹FAB9B项目工程总承包） 格隆汇2月5日丨太极实业(600667.SH)公布，公司子公司信息产业电子第十一设计研究院科技工程股份 有限公司（以下简称"十一科技"）与上海建工四建集团有限公司（以下简称"上海四建"）组成联合体， 参与了华虹宏力半导体（无锡）有限公司的华虹FAB9B项目工程总承包（以下简称"项目"）的投标。根 据无锡市公共资源交易中心发布的《无锡市工程建设项目中标人公示（编号：WXXQ202601001- X01）》（https://ggzyjy.wuxi.gov.cn/doc/2026/02/03/4727873.shtml），十一科技、上海四建组成的联合 体为项目拟确定中标人，本次预中标项目投标报价为人民币37.78亿元，根据《联合体协议书》约定的 分工，预计十一科技合同工作量占比为98.46%，对应金额约为37.19亿元。以上金额占比仅为初步估算 数据，最终实际金额以确定中标后签订的正式合同为准。 ...

智通财经APP讯，太极实业(600667.SH)发布公告，公司子公司十一科技与上海四建组成联合体，参与 了华虹宏力半导体(无锡)有限公司的华虹FAB9B项目工程总承包的投标。根据公示，联合体为项目拟确 定中标人，投标报价为37.78亿元。十一科技为联合体牵头人，预计合同工作量占比为98.46%，金额约 为37.19亿元。 该项目预中标体现了十一科技在国内集成电路产业工程领域的EPC领先地位。如能确定中标并签订正式 合同，因项目存在跨年实施，且受合同签订时间、开工日期及实施进度影响，对公司2026年度业绩的影 响存在不确定性。 ...

该项目预中标体现了十一科技在国内集成电路产业工程领域的EPC领先地位。如能确定中标并签订正式 合同，因项目存在跨年实施，且受合同签订时间、开工日期及实施进度影响，对公司2026年度业绩的影 响存在不确定性。 太极实业（600667）(600667.SH)发布公告，公司子公司十一科技与上海四建组成联合体，参与了华虹 宏力半导体(无锡)有限公司的华虹FAB9B项目工程总承包的投标。根据公示，联合体为项目拟确定中标 人，投标报价为37.78亿元。十一科技为联合体牵头人，预计合同工作量占比为98.46%，金额约为37.19 亿元。 ...

证券代码：600667 证券简称：太极实业 公告编号：临 2026-008 无锡市太极实业股份有限公司 关于累计诉讼、仲裁事项的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要事项提示： ●案件所处的诉讼阶段：受理阶段 ●上市公司所处的当事人地位：无锡市太极实业股份有限公司（以下简称"公 司"）子公司信息产业电子第十一设计研究院科技工程股份有限公司（以下简称 "十一科技"）及信息产业电子第十一设计研究院科技工程股份有限公司海门分 公司（以下简称"十一科技海门分公司"）为被告。 ●涉案金额：本次诉讼涉案金额包括工程款 1,108.14 万元及资金占用损失。 自公司前次披露累计诉讼、仲裁情况公告后，公司及控股子公司连续十二个月内 未披露的诉讼和仲裁事项累计涉案金额为 85,798.34 万元（含本次诉讼事项）， 占公司最近一期经审计净资产的 10.09%。 ●由于部分诉讼、仲裁案件尚未开庭审理、调解、判决或结案，目前尚不能 确定对公司本期利润或期后利润的影响。公司将根据案件进展情况，按照法律法 规及企业会计准则进行相应会 ...